Clinical trial · Observational
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Pilot Study of Cancer Resistance in Humans
NCT00899496CI-TRIAL-00027847completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Studying samples of blood and tissue in the laboratory from patients with cancer and from healthy participants may help doctors learn more about cancer. PURPOSE: This laboratory study is looking at an assay in determining cancer resistance in patients with metastatic cancer and in healthy participants.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| immunological diagnostic method | Other | — | UNRESOLVED |
| physiologic testing | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Cell killing ability (positive or negative)
- timeFrame
- Day 180
- measure
- Percentage of cells killed
- timeFrame
- Day 180
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 120 Years
Show eligibility criteria text
Inclusion Criteria: -Meets 1 of the following criteria: * Diagnosis of metastatic cancer including, but not limited to, any of the following: * Stage IV non-small cell lung cancer * Extensive-stage small cell lung cancer * Metastatic testicular cancer * Stage IV breast carcinoma * Stage III or IV ovarian carcinoma * Stage IV endometrial carcinoma * Stage IV prostate carcinoma * Stage IV colorectal or pancreatic cancer * Stage IV renal cancer * Stage III or IV non-Hodgkin's lymphoma * Stage IV bladder cancer * Stage III multiple myeloma (Salmon-Durie staging) * Metastatic melanoma * Metastatic sarcoma * Healthy participant, meeting the following criteria: * No prior cancer * Over 50 years of age Exclusion Criteria: * Serious medical or psychiatric condition that would preclude study compliance * Chemotherapy or radiotherapy within the past 3 months (patient) * Prior immunosuppressive therapy or radiotherapy for any disease (healthy participant)
References
Publications (0)
Data not yet available
No reference posted for this study.